MADELYN SCHLEGEL: Open Payments
NPI 1477042919 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,192 in 92 payments from 23 companies in 2025. Trend: 2023 $1,690 · 2024 $2,530 · 2025 $2,192
Food & beverage: $2,192
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $431 |
| Amgen Inc. | 15 | $379 |
| PFIZER INC. | 16 | $307 |
| AstraZeneca Pharmaceuticals LP | 8 | $255 |
| UCB, Inc. | 9 | $190 |
| Janssen Biotech, Inc. | 8 | $119 |
| Janssen Pharmaceuticals, Inc | 3 | $79 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $69 |
| Indivior Inc. | 2 | $41 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $34 |
Products named: XELJANZ, SKYRIZI, SAPHNELO, EVENITY, RINVOQ, Bimzelx, TREMFYA, OTEZLA.
Industry payments across NY — which companies pay providers there.
